mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.003 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.76 |
0.004 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.006 |